Home » Stocks » DYAI

Dyadic International, Inc. (DYAI)

Stock Price: $7.45 USD -0.21 (-2.74%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 204.74M
Revenue (ttm) 1.73M
Net Income (ttm) -8.30M
Shares Out 27.48M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE 20.37
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $7.45
Previous Close $7.66
Change ($) -0.21
Change (%) -2.74%
Day's Open 7.50
Day's Range 7.25 - 7.50
Day's Volume 86,997
52-Week Range 2.51 - 10.98

More Stats

Market Cap 204.74M
Enterprise Value 172.91M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 27.48M
Float 19.22M
EPS (basic) -0.31
EPS (diluted) -0.30
FCF / Share -0.25
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.29M
Short Ratio 11.53
Short % of Float 6.71%
Beta 0.35
PE Ratio n/a
Forward PE 20.37
P/FCF Ratio n/a
PS Ratio 118.53
PB Ratio 5.93
Revenue 1.73M
Operating Income -9.00M
Net Income -8.30M
Free Cash Flow -6.85M
Net Cash 31.83M
Net Cash / Share 1.16
Gross Margin 12.82%
Operating Margin -521.10%
Profit Margin -480.70%
FCF Margin -396.33%
ROA -15.25%
ROE -23.48%
ROIC -29.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(47.65% upside)
Current: $7.45
Target: 11.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth29.77%70.81%27.92%-
Gross Profit0.
Operating Income-9.25-7.57-7.38-5.81
Net Income-8.31-5.69-2.14-3.61
Shares Outstanding27.0027.6728.9236.54
Earnings Per Share-0.31-0.21-0.07-0.10
Operating Cash Flow-5.78-4.41-1.69-6.03
Free Cash Flow-5.78-4.41-1.69-6.03
Cash & Equivalents34.2241.2047.6948.94
Net Cash / Debt34.2241.2047.6948.94
Book Value35.8642.4549.9857.69
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Dyadic International, Inc.
Country United States
Employees 6
CEO Mark A. Emalfarb

Stock Information

Ticker Symbol DYAI
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: DYAI
IPO Date November 5, 2004


Dyadic International, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd., as well as with the Israel Institute for Biological Research; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; research collaboration with Sanofi-Aventis Deutschland GmbH; research and commercialization collaboration with Serum Institute of India Pvt.; and nonexclusive research collaboration with WuXi Biologics. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.